(Q30482547)

22 June 2017

1 reference

title

The use of antidepressants to treat attention deficit hyperactivity disorder in adults (English)

1 reference

22 June 2017

The Use of Antidepressants to Treat Attention Deficit Hyperactivity Disorder in Adults (English)

1 reference

https://api.crossref.org/works/10.1177/02698811030173016

15 March 2024

1 reference

attention deficit hyperactivity disorder

1 reference

1 reference

https://api.crossref.org/works/10.1177/02698811030173016

15 March 2024

1

Ian D. Maidment

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14513926

15 March 2024

language of work or name

English

0 references

publication date

1 September 2003

1 reference

full work available at URL

22 June 2017

http://journals.sagepub.com/doi/pdf/10.1177/02698811030173016

1 reference

https://api.crossref.org/works/10.1177/02698811030173016

Journal of Psychopharmacology

15 March 2024

published in

1 reference

22 June 2017

17

1 reference

22 June 2017

3

1 reference

22 June 2017

332-336

1 reference

An Inventory for Measuring Depression

22 June 2017

1 reference

https://api.crossref.org/works/10.1177%2F02698811030173016

Parent and Teacher Ratings of ADHD Symptoms: Psychometric Properties in a Community-Based Sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F02698811030173016

The assessment of anxiety states by rating

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F02698811030173016

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F02698811030173016

Adult psychiatric status of hyperactive boys grown up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F02698811030173016

Methylphenidate effects on symptoms of attention deficit disorder in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F02698811030173016

A clinical and demographic profile of a sample of adults with attention deficit hyperactivity disorder, residual state

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F02698811030173016

A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F02698811030173016

Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F02698811030173016

The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F02698811030173016

Psychiatric status of hyperactives as adults: a controlled prospective 15-year follow-up of 63 hyperactive children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F02698811030173016

Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F02698811030173016

A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F02698811030173016

Bupropion treatment of attention-deficit hyperactivity disorder in adults

21 January 2018

series ordinal

19

1 reference

https://api.crossref.org/works/10.1177/02698811030173016

Attention deficit disorder ('minimal brain dysfunction') in adults. A replication study of diagnosis and drug treatment

15 March 2024

series ordinal

20

1 reference

https://api.crossref.org/works/10.1177/02698811030173016

A systematic assessment of tricyclic antidepressants in the treatment of adult attention-deficit hyperactivity disorder

15 March 2024

series ordinal

21

1 reference

https://api.crossref.org/works/10.1177/02698811030173016

15 March 2024

Identifiers

1 reference

22 June 2017

1 reference